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Utility of nitrate reductase assay for detection of multidrug-resistant 
Mycobacterium tuberculosis in a low resource setting
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  Instituto Nacional de Enfermedades Respiratorias “Emilio Coni”, Administración Nacional de Laboratorios e 
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Introduction. The performance of a drug susceptibility test may change when moving from the research 
stage to implementation on a population level in actual public health practice.
Objective. The performance of a rapid drug susceptibility test was described for detecting multidrug-
resistant Mycobacterium tuberculosis when implemented in the routine workflow of a low-resource 
reference laboratory.
Materials and methods. A prospective study was done comparing the performance of the nitrate 
reductase assay with the conventional proportion method for rifampicin and isoniazid on 364 isolates 
were obtained from multidrug-resistant tuberculosis risk patients referred from diffrent Colombian 
laboratories.
Results. When compared with the proportion method, the nitrate reductase assay sensitivity was 86.8% 
and 84.9% for rifampicin and isoniazid, respectively, whereas nitrate reductase assay specificity was 
100% for isoniazid and rifampicin. Nitrate reductase assay sensitivity was significantly higher when the 
age of isolate was less than 70 days. A sensitivity of 94.4% dropped to 78.1% for rifampicin resistance 
for fresh and old isolates, respectively (Fisher exact test, p=0.05). For isoniazid resistance using fresh 
and old isolates, 94.7% vs.74.3% sensitivities, were achieved (chi square test, p=0.03). The proportion 
of nitrate reductase assay ambiguous results was significantly higher in multidrug-resistant than in non-
multidrug-resistant isolates (17.6% vs. 4.0%, chi square test, p<0.005).
Conclusions. The nitrate reductase assay demonstrated provided reliable results for antibiotic 
resistance. However, using old cultures leds to a higher proportion of false sensitive results; furthermore, 
the nitrate reductase assay capability to detect multidrug-resistant tuberculosis decreased due to a 
higher proportion of non-interpretable results. 
Key words: Mycobacterium tuberculosis, drug resistance, microbial sensitivity tests, methods, nitrate 
reductase.
Utilidad del ensayo de nitrato reductasa en la detección de Mycobacterium tuberculosis 
multirresistente en caso de recursos limitados
Introducción. El rendimiento de cualquier prueba rápida de sensibilidad a medicamentos para 
Mycobacterium tuberculosis puede cambiar cuando se pasa de la etapa de investigación a su 
implementación en la práctica de salud pública.
Objetivo. Describir el rendimiento del ensayo de nitrato reductasa para detectar tuberculosis 
multirresistente en la rutina de trabajo de un laboratorio de referencia con recursos limitados.
Materiales y métodos. Se comparó prospectivamente la utilidad del ensayo de nitrato reductasa con el 
método de las proporciones para la detección de resistencia a isoniacida y rifampicina en aislamientos 
de pacientes con riesgo de multirresistencia.
Resultados. Comparando con el método de las proporciones, la sensibilidad del ensayo de nitrato 
reductasa fue de 86,8 % y 84,9 % para rifampicina e isoniacida, respectivamente; la especificidad fue 100 
% para rifampicina e isoniacida. La sensibilidad del ensayo de nitrato reductasa fue significativamente 
mayor cuando se emplearon aislamientos en los cuales el tiempo entre la realización del cultivo y la 
inoculación del ensayo de nitrato reductasa no superaba 70 días: 94,3 % Vs. 78,1 % para resistencia 
a rifampicina usando aislamientos frescos o envejecidos, respectivamente; prueba exacta de Fisher, 
p=0,05; 94,4 % Vs. 74,3 % para resistencia a isoniacida usando aislamientos frescos o envejecidos, 
respectivamente, y prueba de ji al cuadrado, p=0,03. La proporción de resultados no interpretables en 
el ensayo de nitrato reductasa fue mayor en los aislamientos multirresistentes que en los otros
Conclusiones. La experiencia con el ensayo de nitrato reductasa demuestra que produce resultados 
resistentes confiables. El uso de cultivos envejecidos conduciría a una mayor proporción de resultados 
falsos sensibles, mientras que su capacidad para detectar multirresistencia disminuye a consecuencia 
de una mayor proporción de resultados no interpretables.
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The spread of multidrug-resistant strains of 
Mycobacterium tuberculosis has become a major 
public health concern and poses a formidable 
challenge to tuberculosis control due to its 
complex diagnostic and treatment challenges. 
Conventional methods for drug susceptibility 
testing of Mycobacterium tuberculosis, such as 
the proportion method, the absolute-concentration 
method, and the resistance ratio method, are 
used globally but have a long turnaround time 
(1). The time lag poses a significant threat to the 
patient, the community and health care workers. 
The commercial liquid culture BACTEC MGIT 960 
method is faster but requires costly equipment and 
substrate, and is not feasible in most resource-
poor settings. Several other promising techniques, 
genetic as well as phenotypic, have been recently 
reported (2,3). One affordable option for rapid 
drug resistance detection is the nitrate reductase 
assay (NRA) that uses colorimetric detection of 
nitrite as an indication of growth. It requires neither 
elaborate equipment nor expensive substrates 
or reagents. A recent review (4) pointed out that 
although nitrate reductase assay has been shown 
to be highly sensitive and specific in the detection 
of rifampicin and isoniazid resistance, additional 
studies are required to determine its performance 
in the target population, i.e. a population in which 
multidrug-resistance tuberculosis is suspected. In 
a previous study carried out in our laboratory (5) , 
this technique was compared with other rapid drug 
susceptibility testing methods using a panel of 64 
strains. The NRA appears as rapid, inexpensive, 
and easy to perform (5). Nevertheless, the 
performance characteristics of drug susceptibility 
tests may change when moving from the research 
stage to implementation at a population level 
in actual public health practice (6). The current 
study was designed to test the performance of 
nitrate reductase assay for rifampicin and isoniazid 
resistance detection in the routine workflow of a 
reference laboratory with limited resources.  This 
laboratory routinely receives isolates from groups 
targeted for drug susceptibility testing, as defined 
by the National Tuberculosis Program norms.
Materials and methods
Strains and inoculum preparation
The nitrate reductase assay was evaluated in 
364 Mycobacterium tuberculosis complex isolates 
referred to the laboratory for drug susceptibility 
testing. They were obtained from patients who were 
at high risk of multidrug-resistant tuberculosis, as 
specified the National Tuberculosis Program norms, 
with the following critera: (1) contacts with multidrug-
resistant tuberculosis, (2) tuberculosis patients co-
infected with HIV, (3) exposure in institutions that 
have multidrug-resistant tuberculosis outbreaks or 
a high multidrug-resistant tuberculosis prevalence, 
(4) patients with history of previous tuberculosis 
treatment and (5) those who remain positive after 
two o more months of treatment. All clinical isolates 
were tested prospectively in a blind manner for 
both nitrate reductase assay and the proportion 
method on Lowenstein Jensen, which served as 
the reference standard. Colonies from Lowenstein 
Jensen were transferred to a tube containing 6-9 
sterile glass beads and 3-4 ml of 7H9-S broth 
[(Middlebrook 7H9 broth base (Difco, Sparks, 
MD, USA; 4.7g per liter), with 0.2% glycerol, 
supplemented with 10% oleic-albumin-dextrose-
catalase (OADC; Becton Dickinson, Sparks, MD, 
USA)]. Tubes were vigorously agitated and clumps 
were allowed to settle for 30 min. The supernatants 
were then adjusted with distilled water to equal 
the density of 1.0 Mc Farland standard for use in 
nitrate reductase and proportion method assays. 
The reference strain H37Rv was tested in parallel.
Antituberculous drugs
Rifampicin, isoniazid, ethambutol and streptomycin 
were obtained in a powdered formulation from 
Sigma Chemical Co. (St Louis, MO, USA). Stock 
solutions of isoniazid, ethambutol and streptomycin 
were prepared in deionized water at 10 g/L and 
rifampicin was prepared in dimethylsulfoxide at 20 
g/L. Stock solutions were kept at –20°C for no more 
than one month.
Proportion method
The proportion method was performed on 
Lowenstein Jensen medium according to Canetti et 
al. (1) with the recommended critical concentrations 
of 0.2 µg/ml for isoniazid, 40 µg/ml for rifampicin, 2 
µg/ml for ethambutol and 4 µg/ml for streptomycin. 
The results were read for the first time on 28th 
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day. If this reading demonstrated resistance, no 
further readings were required. If the result of the 
first reading was susceptible, a second and final 
reading was made on day 42. The results from 
the proportion method served as the reference 
standard.
Nitrate reductase assay
The nitrate reductase assay was performed as 
described Angeby et al. (7). Briefly, the antibiotic 
was included in the Lowenstein Jensen medium at 
a concentration of: 0.2 µg/ml for isoniazid, 40 µg/
ml for rifampicin, 2 µg/ml for ethambutol and 4 µg/
ml for streptomycin; 1000 mg/L of KNO3 was also 
added. Part of the inoculum was adjusted to equal 
the density of the No 1.0 McFarland standard and 
diluted 1:10 in distilled water. For each isolate, 0.2 
ml of the undiluted inoculum was added into the 
tubes containing Lowenstein Jensen medium with 
KNO3 and the anti-tuberculosis drugs; and 0.2 ml of 
the 1:10 dilution was inoculated into drug-free media 
containing KNO3 (tubes in triplicate), which served 
as the controls. Tubes were incubated at 37°C for 
14 days, and 0.5 ml of a mixture of three reagents 
(1 part 50% HCl, 2 parts 0.2% sulfanilamide and 
2 parts 0.1% N-1-naphthylenthylenediamine 
dihydrochloride) was added to one drug-free control 
tube after 7 days of incubation. If the color changed 
to pink, then tubes with drugs were tested. An 
isolate was considered resistant if the color change 
in the drug-tube was greater than in the 1:10 diluted 
growth control on the same day. Drug-free control 
tubes that did not show any color change were 
further incubated and the procedure repeated at 
day 10 and day 14. Non-interpretable results were 
defined as those obtained when isolates failed to 
show any color change in the drug-free control tube 
even at day 14.
Data analysis
Statistical analyses were carried out with Epi 
Info version 6.04. The nitrate reductase assay/ 
proportion method comparisons were evaluated in 
terms of sensitivity (ability to detect true resistance) 
and specificity (ability to detect true susceptibility). 
To demonstrate the effect of the time period from 
specimen culture to nitrate reductase assay 
inoculation on the performance of this assay, the 
assays were separated in two groups, ≤70 and 
>70 days and the percent sensitivity compared. 
chi square or Fisher´s exact tests provided 
significance tests for between-groups distribution 
of discontinuous variables. Factors associated with 
non-interpretable nitrate reductase assay results 
were also examined. Variables analyzed included 
multidrug-resistant status and time (in days) from 
the specimen culture to nitrate reductase assay 
inoculation (2 groups: ≤70 and >70 days). The 
odds ratios and 95% confidence intervals were 
estimated using binary logistic regression, with 
“interpretable nitrate reductase assay results” 
status as the outcome. 
Results
A total of 364 specimens were received from 344 
patients. Results of 39 isolates (10.7%) were 
unavailable using the conventional method because 
of failure to grow. Among the remaining 325 
isolates, 81 (24.9%) were rifampicin-resistant and 
88 (27.1%) isoniazid-resistant. Of the rifampicin-
resistant strains, 91.4 % (74/81) were also resistant 
to isoniazid (multidrug-resistant); 14 strains were 
isoniazid-resistant and rifampicin-susceptible. Of 
the 325 isolates that had available results by the 
proportion method, 302 (92.9%) were interpretable 
by the nitrate reductase assay. The comparison 
data comparing the nitrate reductase assay with 
the conventional proportion method are shown in 
table 1. Nitrate reductase assay results in detecting 
multidrug-resistant and non-multidrug resistant 
strains were available in a median of 14 and 10 
days from date of inoculation, respectively. Overall, 
the median time for the availability of the results 
was 10 days.
The sensitivity of the nitrate reductase assay 
was as follows: isoniazid (84.9%), streptomycin 
(58.8%), ethambutol (54.5%) and rifampicin 
(86.8%).  The specificity was 100% for isoniazid and 
rifampicin, and higher than 99% for streptomycin 
and ethambutol (table 1). The overall agreement 
between the nitrate reductase assay and the 
proportion method was 96.5%.
Rifampicin and isoniazid sensitivities were much 
lower than anticipated from previous studies (4). 
Upon nitrate reductase assay repetition of those 
isolates formerly classified as false-susceptible, we 
found that using fresh subcultures of the 9 isolates 
classified as false-rifampicin susceptible strains, 
4 could be classified as resistant. Similarly, 5 of 
the 11 false-isoniazid susceptible strains were re-
classified as resistant. These data gave an new 
overall sensitivity of 92.6% (63/68) and 91.8% 
(67/73) for rifampicin and isoniazid, respectively. 
All of the re-classified false-susceptible results 
were formerly obtained using isolates more than 
70 days intervened between specimen culture to 
assay inoculation. This suggested that the low 
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levels of sensitivity previously obtained using 
the Mycobacterium tuberculosis isolates as they 
arrived (regardless of previous manipulation or 
culture maintenance conditions), appeared to be 
related to the the period from specimen culture to 
nitrate reductase assay inoculation. In summary, 
the rifampicin sensitivities were significantly 
higher (Fisher exact test, p=0.05) when analyzing 
isolates in which the days from specimen cultures 
to nitrate reductase assay inoculation were less 
than 70 [94.4% (34/36)] in comparison with 
those of more than 70 days [78.1% (25/32)]. For 
isoniazid resistance a similar data trend was seen 
[94.7% (36/38) vs.74.3% (26/35), chi square test, 
p=0.03)].
Overall, 23 of the 325 (7.1%) isolates gave nitrate 
reductase assay non-interpretable results. These 
non-interpretable results were more common among 
multidrug-resistant strains (13 of 74; 17.6%) than 
among non multidrug-resistant strains (10 of 251; 
4.0%) (OR=4.7, 95%CI: 1.8-12.6). Furthermore, no 
associations were discerned between the time (in 
days) from the specimen culture to nitrate reductase 
assay inoculation (2 groups: ≤70 and >70 days) 
and the proportion of interpretable results (OR=0.8, 
95%CI: 0.3-2.2).
Discussion
This study assessed the performance of the 
nitrate reductase assay on a population at risk of 
multidrug-resistant tuberculosis (prevalence of 
multidrug-resistant, 22.8%) in the routine workflow 
of a low-resource reference laboratory. It provided 
support for the findings of earlier studies made on 
isolates maintained at low temperatures (7-12), as 
the evaluation was made under more controlled 
methodological conditions. These conditions were 
specified as follows: (1) the study was performed 
in an appropriately broad group of patients with 
Table 1. Drug susceptibility testing of 302 Mycobacterium tuberculosis strains by the nitrate reductase assay and the proportion 
method.
Drug Nitrate reductase Proportion method Agreement (%)
 assay Resistant Susceptible 
Isoniazid Resistant 62 0 96.4
 Susceptible 11 229 
Streptomycin Resistant 20 2 94.7
 Susceptible 14 266 
Ethambutol Resistant 6 1 98.0
 Susceptible 5 290 
Rifampicin Resistant 59 0 97.0
 Susceptible 9 234 
and without multidrug-resistant tuberculosis and in 
pertinent patients groups (without selection bias); 
(2) the nitrate reductase assay and the proportion 
method were made in all patients simultaneously 
(preventing verification bias); (3) all nitrate 
reductase assay results were interpreted by staff 
members who were unaware of the other test 
results, using an appropriate reference standard 
for comparison; and (4) in contrast with previous 
evaluations, in which bacilli to be tested were 
obtained from colonies from fresh subcultures 
in solid medium (5,7,8,11,12), the present study 
analyzed the isolates, as they arrived, regardless 
of previous manipulation or culture maintenance 
conditions. 
Some isolates had been submitted from as far as 
Argentina and may have spent several days in 
transit. In other laboratories, isolates obtained at the 
time of diagnosis are sent for rapid identification of 
multidrug-resistant statis during the waiting period 
for incubation of sputa obtained from patients who 
remain positive after month 2 or more of treatment.. 
These factors explain, at least in part, the high 
proportion of old isolates included in the current 
study. No relationship was observed between the 
degree of positivity obtained by direct smear or 
culture, and  isolate arrival time (data not shown). 
Recommendations have been made for inoculating 
drug susceptibility testing media by using dilutions 
of a standard inoculum prepared by scraping freshly 
grown colonies (of no more than four to five weeks 
old); however, in case of using older cultures, it 
have been deemed acceptable to prepare lower 
dilutions of the standard inoculum (13).
At the programmatic level, the most important 
susceptibility data that are likely to affect a 
change in therapy are those for the detection of 
multidrug-resistant tuberculosis. Delays in initiating 
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multidrug-resistant tuberculosis treatment where 
appropriate has serious consequences, especially 
if patients are attending the health facility every 
day to receive an ineffective treatment.  During this 
period,  multidrug-resistant tuberculosis may be 
transmitted to household contacts, other patients 
and health care personnel.  
In the current study, the sensitivity of the nitrate 
reductase assay was 86.8% and 84.9% for 
rifampicin and isoniazid, respectively. These values 
are outside the published range of rifampicin and 
isoniazid sensitivities in a recent meta-analysis 
(88-100% for rifampicin sensitivity and 87-100% for 
isoniazid sensitivity); these low levels of sensitivities 
appear related to the period from specimen culture 
to nitrate reductase assay inoculation. Martin et al. 
(10), in their multicenter evaluation of this technique 
using a set of 30 isolates, stated that to perform 
nitrate reductase assay it is important to use fresh 
cultures. In this way, upon nitrate reductase assay 
repetition of all false rifampicin- and isoniazid-
susceptible strains using fresh subcultures, the 
values of sensitivity increased up to 93% and 92% 
for rifampicin and isoniazid, respectively.
Overall, 7.1% isolates that had available results 
by the proportion method gave nitrate reductase 
assay non-interpretable results. After evaluating 
the factors related with nitrate reductase assay 
non-interpretable results, the multidrug-resistant 
strains were found to be associated with a 
higher proportion of nitrate reductase assay non-
interpretable results, and these results were not 
related with the days from specimen cultures to 
nitrate reductase assay inoculation. This is not 
surprising, considering that the results of the nitrate 
reductase assay for multidrug-resistant isolates 
were available later than non- multidrug-resistant 
isolates. Isoniazid resistant strains have shown 
lower rates of multiplication than pan-sensitive 
ones and different requirements for optimal growth 
have also been reported for isoniazid-resistant 
isolates (14-16). This possibly explains, in part, 
their failure to grow after the 14-day period of 
nitrate reductase assay incubation. Moreover, the 
proportion method gave interpretable results; this 
excluded the possibility that the non-interpretable 
nitrate reductase assay results were associated to 
the use of a low bacilli inoculum, as both methods 
were made at the same time by diluting the same 
1.0 McFarland standard inoculum. 
The nitrate reductase assay provided reliable 
isoniazid and rifampicin positive (resistant) results 
within a mean of 14 days after receiving the patient 
isolate in the reference laboratory. In accordance 
with previous studies (5,7-12,17-19), its 100% 
specificity for rifampicin and isoniazid, avoids in a 
non-multidrug-resistant patient which is conducting 
a first-line drug treatment, any change to a treatment 
with second line drugs to that is more toxic, less 
effective and very expensive.
Susceptibility testing for Mycobacterium tuberculosis 
is complex and concordance among even 
regional laboratories performing reliable standard 
testing is particularly variable for ethambutol and 
streptomycin (20). The current findings with these 
two drugs agreed with previous and recent data for 
nitrate reductase assay (5,21,22), demonstrating 
insufficient concordance of the assay with the 
normally recommended standards to recommend 
them for routine use. Nonetheless, Rosales et al. 
(23) have recently evaluated the nitrate reductase 
assay for the rapid detection of resistance to second-
line drugs such as ofloxacin and kanamycin. They 
showed a clear potential of nitrate reductase assay 
for prompt detection of extensively drug-resistant 
tuberculosis cases, although they stated the need 
of further studies to optimize the testing of second-
line drugs. 
In November 2009, the WHO Strategic and 
Technical Advisory Group for Tuberculosis stated 
that, based on the published evidence, the 
performance of  non-commercial drug susceptibility 
tests were acceptable under stringent laboratory 
protocols when applied in reference/national 
laboratories in selected settings. Furthermore, 
they endorsed the selective use nitrate reductase 
assay for screening of patients suspected of having 
multidrug-resistant tuberculosis, again under clearly 
defined programmatic and operation conditions 
(24). As demonstrated herein, experience with this 
technique under field conditions confirms previous 
observations about nitrate reductase assay ability 
to provide reliable isoniazid and rifampicin resistant 
results. Nevertheless, when using it in routine 
laboratory diagnosis, the following factors influence 
the nitrate reductase assay capability to detect 
multidrug-resistant tuberculosis: (1) fresh cultures 
must be used (at least <70 days from specimen 
culture to nitrate reductase assay inoculation), and 
(2) multidrug-resistant isolates may be associated 
with a higher proportion of nitrate reductase 
assay non-interpretable results, thus resulting 
in a reduction of its capacity to detect multidrug-
resistant tuberculosis.
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